Drug Shortage Report for PIPERACILLIN AND TAZOBACTAM FOR INJECTION

Last updated on 2022-01-29 History
Report ID 153839
Drug Identification Number 02401320
Brand name PIPERACILLIN AND TAZOBACTAM FOR INJECTION
Common or Proper name PIPERACILLIN AND TAZOBACTAM FOR INJECTION
Company Name TELIP, LLC, A SUBSIDIARY OF TELIGENT, INC.
Market Status MARKETED
Active Ingredient(s) PIPERACILLIN TAZOBACTAM
Strength(s) 3G 0.375G
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 3.375G VIAL
ATC code J01CR
ATC description BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date 2022-01-28
Actual start date
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2022-01-29
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 105 LINCOLN AVE
BUENA, NEW JERSEY
UNITED STATES 08310
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2022-01-29 English Compare
v2 2022-01-28 French Compare
v1 2022-01-28 English Compare

Showing 1 to 3 of 3